Recent advances in nitrogen-containing heterocycles for targeted anticancer therapy

Nitrogen-containing heterocycles have become essential frameworks in the formulation and advancement of contemporary anticancer medicines owing to their structural variety and distinctive pharmacological attributes. These chemicals, including indole, imidazole, pyrrole, triazole, and piperazine, have considerable biological activity via interactions with critical molecular targets implicated in cancer growth. The incorporation of nitrogen atoms into heterocyclic rings improves the compounds' binding affinity, solubility, metabolic stability, and selective targeting of nucleic acids and proteins. This research emphasizes the significance of nitrogen-containing heterocycles in several categories of anticancer medicines, particularly concentrating on alkylating agents like nitrogen mustards, triazines, nitrosoureas, and ethylenimine derivatives. The capacity of these drugs to disrupt DNA synthesis, repair, and critical signaling pathways underpins their anticancer efficacy. Ongoing breakthroughs in heterocyclic chemistry render these molecules very promising for the creation of more effective, selective, and less toxic targeted therapeutics for diverse cancer types.